Global Industry Analysts, Inc., July 2009, Pages: 1810
) II-7
PatentExpiries of Major Drugs: 2009-2012 II-8
Patient Spending II-8
Operational Restructuring II-9
Rising R&D Costs Call for Improved Efficiency II-9
Concerns Over Drug Safety and Side Effects